PMC:7696151 / 110658-111184 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
4064 68-76 Species denotes patients Tax:9606
4065 469-476 Species denotes patient Tax:9606
4066 498-505 Species denotes patient Tax:9606
4190 92-100 Disease denotes COVID-19 MESH:C000657245
4191 270-275 Disease denotes Cough MESH:D003371
4192 382-391 Disease denotes pneumonia MESH:D011014
4193 422-431 Disease denotes Pneumonia MESH:D011014
4194 489-493 Disease denotes rash MESH:D005076
4195 517-525 Disease denotes headache MESH:D006261

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T262 270-275 Phenotype denotes Cough http://purl.obolibrary.org/obo/HP_0012735
T263 382-391 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T264 422-431 Phenotype denotes Pneumonia http://purl.obolibrary.org/obo/HP_0002090
T265 517-525 Phenotype denotes headache http://purl.obolibrary.org/obo/HP_0002315

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T754 0-526 Sentence denotes Chen et al. (2020) [6] Randomized, parallel-group clinical trial62 patients suffering from COVID-19 HCQ group -> 400 mg/day HCQControl group -> SOCDay 5 Body temperature recovery time in the HCQ group was shorter than the control group (2.2 vs. 3.2 days, p = 0.0008).Cough remission time was significantly decreased in the HCQ group (2.0 vs. 3.1 days, p = 0.0016).Improvement of pneumonia in HCQ group (80.6% vs. 54.8%)Pneumonia absorption in HCQ group (61.3%) One patient developed a rash.One patient reported a headache.